Scientific Programme
Programme, Thursday, 16 October 2008
19.00 – 19.30
Opening and welcome
Z. Culig, Innsbruck (AT)
N. Maitland, York (GB)
N. Malats, Madrid (ES)
J. Reventós, Barcelona (ES)
19.30 – 20.00
Keynote lecture
From inception to trade sale: The entrepreneur's perspective
J. Jean-Mairet, Barcelona (ES)
18th Meeting of the European Society for Urological Research (ESUR)
Programme, Friday, 17 October 2008
07.30 – 09.00
Training course
Basic molecular biology for urologists
Coordinator: M. Abal, Barcelona (ES)
Molecular pathology
J. Castellvi, Barcelona (ES)
Proteomics
D. Andreu, Barcelona (ES)
Gene expression
F. Núñez, Barcelona (ES)
Stem cells
M. Santos, Lisbon (PT)
Cytomics
J. Pétriz, Barcelona (ES)
Animal models
A. Doll, Barcelona (ES)
08.45 – 09.00
Welcome refreshments
09.00 – 11.30
Survival and metastatis in urological cancers
Chairs: C. Bangma, Rotterdam (NL)
Z. Culig, Innsbruck (AT)
09.00 – 09.30
Cell signaling in prostate cancer metastasis
L. Languino, Worcester (US)
09.30 – 10.00
Mechanisms of progression in bladder cancer
F. Real, Madrid (ES)
10.00 – 10.30
Calcium signatures of prostate cancer
N. Prevarskaya, Lille (FR)
10.30 – 11.00
Refreshment break
11.00 – 11.30
Mechanisms of osteoblast activation in prostate cancer bone metastasis
M. Cecchini, Berne (CH)
11.30 – 12.30
Oral session 1
Selected oral presentations: abstract numbers 1-4
12.30 – 13.30
Poster guided tour
Chairs: L. Languino, Worcester (US)
M. Cecchini, Berne (CH)
N. Prevarskaya, Lille (FR)
13.30 – 15.00
Lunch and poster session 1
Selected poster presentations: abstract numbers 5-44
4
18th Meeting of the European Society for Urological Research (ESUR)
15.00 – 17.00
Genetic susceptibility and urological disorders
Chairs: A. Bjartell, Malmö (SE)
J. Palou Redorta, Barcelona (ES)
15.00 – 15.30
Familiality of risk and survival in kidney cancer
K. Hemminki, Heidelberg (DE)
15.30 – 16.00
Genetic susceptibility to testicular cancer
E. Rajpert-De Meyts, Copenhagen (DK)
16.00 – 16.30
Bladder cancer genetic susceptibility
N. Rothman, Rockville (US)
16.30 – 17.00
Somatic genetic alterations in prostate cancer
T. Visakorpi, Tampere (FI)
17.00 – 17.30
Refreshment break
17.30 – 18.30
Oral session 2
Selected oral presentations: abstract numbers 45-48
18.30 – 19.30
Special session
International networking in urological research
Chairs:
N. Malats, Madrid (ES)
M. Cecchini, Berne (CH)
Panelists:
N. Maitland, York (GB)
M. Bussemakers, Nijmegen (NL)
B. Schmidt-Drager, Fürth (DE)
T. Visakorpi, Tampere (FI)
5
18th Meeting of the European Society for Urological Research (ESUR)
Programme, Saturday, 18 October 2008
07.30 – 09.00
Training course
Pharmacogenomics for urologists
Coordinator: A. Gonzalez-Neira, Madrid (ES)
Human genome variation and pharmacogenetics: general concepts and analysis tools
A. González Neira, Madrid (ES)
Bioinformatics for pharmacogenomics: a quick overview
A. Navarro, Barcelona (ES)
Association studies: design, analysis and interpretation of results
R. Milne, Madrid (ES)
Recent findings on pharmacogenomic prediction of platinum sensitivity in bladder cancer
J. Bellmunt, Barcelona (ES)
08.45 – 09.00
Welcome refreshments
09.00 – 11.30
Hormones in urological disease
Chairs: G. Jenster, Rotterdam (NL)
T. Visakorpi, Tampere (FI)
09.00 – 09.30
The key role of the androgen receptor in prostate cancer
J. Trapman, Rotterdam (NL)
09.30 – 10.00
Cell-selective knockouts of the androgen receptor: A novel tool in the study of androgen action
G. Verhoeven, Leuven (BE)
10.00 – 10.30
Wnt and Wnt antagonist signaling in prostate cancer
R. Kypta, Bilbao (ES) and London (GB)
10.30 – 11.00
Refreshment break
11.00 – 11.30
Advances in the management of castration resistant prostate cancer
D. Olmos, Sutton (GB)
11.30 – 12.30
Oral session 3
Selected oral presentations: abstract numbers 49-52
12.30 – 13.30
Poster guided tour
Chairs: J. Trapman, Rotterdam (NL)
G. Verhoeven, Leuven (BE)
D. Olmos, Sutton (GB)
13.30 – 15.00
Lunch and poster session 2
Selected poster presentations: abstract numbers 53-89
6
18th Meeting of the European Society for Urological Research (ESUR)
15.00 – 17.50
Scientific basis for clinical trials
Chairs: M. Mancini, Padova (IT)
15.00 – 15.30
Implementation of basic research in clinical trials for bladder and
prostate cancer
C. Bangma, Rotterdam (NL)
15.30 – 16.00
Predicting therapeutic response in bladder cancer: Do we have
biomarkers available?
M. Sanchez-Carbayo Martin, Madrid (ES)
16.00 – 16.30
Anti-angiogenic drugs in adjuvant and neoadjuvant settings in renal
cell carcinoma
J-J. Patard, Rennes (FR)
16.30 – 17.00
Molecular pathways linking inflammation and cancer
P. Allavena, Milan (IT)
17.00 – 17.30
Refreshment break
17.30 – 19.00
Special session
Turning science into value: Urological research as a driver of the new economy
Chairs:
F. Jankevicius, Vilnius (LT)
J. Reventos, Barcelona (ES)
Panelists:
M. Vendrell, Barcelona (ES)
J. Merino, Barcelona (ES)
L. Pareras, Barcelona (ES)
L. Ruiz, Barcelona (ES)
J. Sanfeliu, Barcelona (ES)
7